157 related articles for article (PubMed ID: 11301173)
1. Clotting disorders and placental abruption: homocysteine--a new risk factor.
Eskes TK
Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):206-12. PubMed ID: 11301173
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and human reproduction.
Eskes TK
Clin Exp Obstet Gynecol; 2000; 27(3-4):157-67. PubMed ID: 11214939
[TBL] [Abstract][Full Text] [Related]
3. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review.
Ray JG; Laskin CA
Placenta; 1999 Sep; 20(7):519-29. PubMed ID: 10452905
[TBL] [Abstract][Full Text] [Related]
4. From birth to conception. Open or closed.
Eskes TK
Eur J Obstet Gynecol Reprod Biol; 1998 Jun; 78(2):169-77. PubMed ID: 9622314
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
6. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
Verhoef P; Rimm EB; Hunter DJ; Chen J; Willett WC; Kelsey K; Stampfer MJ
J Am Coll Cardiol; 1998 Aug; 32(2):353-9. PubMed ID: 9708460
[TBL] [Abstract][Full Text] [Related]
7. Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?
Ashfield-Watt PA; Moat SJ; Doshi SN; McDowell IF
Biomed Pharmacother; 2001 Oct; 55(8):425-33. PubMed ID: 11686575
[TBL] [Abstract][Full Text] [Related]
8. [Hyperhomocysteinemia and pregnancy complications].
Sztenc S
Ginekol Pol; 2004 Apr; 75(4):317-25. PubMed ID: 15181872
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.
de Vries JI; Dekker GA; Huijgens PC; Jakobs C; Blomberg BM; van Geijn HP
Br J Obstet Gynaecol; 1997 Nov; 104(11):1248-54. PubMed ID: 9386024
[TBL] [Abstract][Full Text] [Related]
10. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.
van der Molen EF; Arends GE; Nelen WL; van der Put NJ; Heil SG; Eskes TK; Blom HJ
Am J Obstet Gynecol; 2000 May; 182(5):1258-63. PubMed ID: 10819868
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.
van der Molen EF; Verbruggen B; Nováková I; Eskes TK; Monnens LA; Blom HJ
BJOG; 2000 Jun; 107(6):785-91. PubMed ID: 10847236
[TBL] [Abstract][Full Text] [Related]
12. Open or closed? A world of difference: a history of homocysteine research.
Eskes TK
Nutr Rev; 1998 Aug; 56(8):236-44. PubMed ID: 9735677
[TBL] [Abstract][Full Text] [Related]
13. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
[TBL] [Abstract][Full Text] [Related]
14. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia: a risk factor for placental abruption or infarction.
Goddijn-Wessel TA; Wouters MG; van de Molen EF; Spuijbroek MD; Steegers-Theunissen RP; Blom HJ; Boers GH; Eskes TK
Eur J Obstet Gynecol Reprod Biol; 1996 May; 66(1):23-9. PubMed ID: 8735754
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
17. Genetic defects as important factors for moderate hyperhomocysteinemia.
Geisel J; Zimbelmann I; Schorr H; Knapp JP; Bodis M; Hübner U; Herrmann W
Clin Chem Lab Med; 2001 Aug; 39(8):698-704. PubMed ID: 11592436
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
19. Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?
Holmes VA
Proc Nutr Soc; 2003 May; 62(2):479-93. PubMed ID: 14506896
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilia and adverse pregnancy outcome.
Brenner B
Obstet Gynecol Clin North Am; 2006 Sep; 33(3):443-56, ix. PubMed ID: 16962920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
